Relay Therapeutics, Inc. (RLAY) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 3.82B USD. 52-week range 5.85 to 21.27 USD. Data as of 2026-10-09.
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and ...